Clorox (NYSE:CLX) Stock Price Target Raised at JPMorgan Chase & Co.

Clorox (NYSE:CLX) had its target price boosted by analysts at JPMorgan Chase & Co. from $83.00 to $86.00 in a research note issued to investors on Tuesday, Benzinga reports. The brokerage presently has an “underweight” rating on the stock. JPMorgan Chase & Co.‘s price target would indicate a potential downside of 6.77% from the company’s current price.

Other analysts also recently issued reports about the company. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and set a $95.00 price target on shares of Clorox in a report on Monday, October 19th. Jefferies Financial Group lowered Clorox from a “buy” rating to a “hold” rating and cut their target price for the company from $125.00 to $98.00 in a research report on Tuesday, July 28th. Citigroup decreased their target price on Clorox from $97.00 to $90.00 and set a “neutral” rating for the company in a research note on Wednesday, October 14th. Evercore upgraded Clorox from an “underperform” rating to a “hold” rating and set a $99.00 target price for the company in a report on Monday. Finally, Barclays dropped their price target on Clorox from $84.00 to $80.00 and set an “underweight” rating on the stock in a research note on Friday, October 16th. One analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Reduce” and an average target price of $93.29.

Clorox Trading Up 2.6%

Shares of NYSE:CLX traded up $2.34 during mid-day trading on Tuesday, reaching $92.24. 1,661,875 shares of the company’s stock were exchanged, compared to its average volume of 2,645,659. The company has a debt-to-equity ratio of 15.80, a quick ratio of 0.38 and a current ratio of 0.66. Clorox has a twelve month low of $79.12 and a twelve month high of $128.90. The firm has a market capitalization of $11.16 billion, a price-to-earnings ratio of 19.14, a PEG ratio of 2.91 and a beta of 0.59. The business’s fifty day moving average price is $88.27 and its 200-day moving average price is $99.92.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Monday, November 2nd. The company reported $1.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.07 by $0.48. The business had revenue of $1.91 billion during the quarter, compared to the consensus estimate of $1.88 billion. Clorox had a return on equity of 522.23% and a net margin of 8.74%. Clorox’s quarterly revenue was up 33.3% on a year-over-year basis. During the same period in the prior year, the business posted $0.85 earnings per share. On average, research analysts predict that Clorox will post 5.66 EPS for the current fiscal year.

Hedge Funds Weigh In On Clorox

Hedge funds have recently modified their holdings of the company. Ancora Advisors LLC bought a new stake in Clorox during the second quarter worth $28,000. Avalon Trust Co purchased a new position in Clorox in the second quarter worth $29,000. Markowski Investments bought a new position in Clorox in the 2nd quarter valued at $30,000. Root Financial Partners LLC grew its stake in Clorox by 83.8% in the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock valued at $33,000 after purchasing an additional 145 shares during the period. Finally, Pension & Wealth Management Advisors Inc. purchased a new stake in shares of Clorox during the 3rd quarter valued at $26,000. Institutional investors own 78.53% of the company’s stock.

Key Headlines Impacting Clorox

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Quarterly results exceeded expectations. Clorox reported adjusted earnings of $1.55 per share, well above the $1.07 consensus estimate, while revenue rose 33.3% year over year to $1.91 billion, topping the $1.88 billion forecast. Clorox Surpasses Q1 Earnings and Revenue Estimates
• Positive Sentiment: Margin recovery efforts are showing progress. Productivity gains, strategic pricing and anticipated savings from the GOJO integration are helping offset higher input costs, supporting management’s confidence in its recovery plans. Productivity Gains and Strategic Pricing Drive Margin Recovery
• Positive Sentiment: Analyst sentiment improved. Evercore ISI upgraded Clorox from “underperform” to “in line” with a $99 price target, citing the new CEO’s turnaround experience and potential for earnings recovery. Evercore ISI Upgrades Clorox
• Neutral Sentiment: Fiscal 2027 guidance was maintained. Clorox forecasts adjusted EPS of $5.70-$6.00 and revenue of $7.6 billion-$7.7 billion, broadly in line with analyst expectations. Clorox Reports Fiscal 2027 Results
• Negative Sentiment: Cost inflation remains a key risk. Management expects rising input costs and margin pressures to push results toward the lower end of its EPS range, increasing the importance of pricing actions, productivity savings and the GOJO integration. Clorox Earnings Call Highlights Inflation and Margin Pressures

Clorox Company Profile

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt’s Bees personal care items.